Phase 2 study of nab-sirolimus in patients with well-differentiated and advanced/metastatic neuroendocrine tumors of the gastrointestinal tract, lung, or pancreas. Addition of metastasis-directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results